Penumbra, Inc. (PEN) Tops Q3 EPS by 16c, reiterates guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Penumbra (PEN) PT Raised to $241 at Deutsche Bank
October 31, 2024 5:46 AM EDTDeutsche Bank analyst Pito Chickering raised the price target on Penumbra (NYSE: PEN) to $241.00 (from $205.00) while maintaining a Buy rating.
The analyst comments "3Q revenues of $301mm came in comfortably ahead of the Streets $297mm, equating to +11% yr/yr growth with the beat driven by upside in Thrombectomy and Embolization/Access more or less in line. Most importantly, 3Q growth in the allimportant US VTE category was a robust +32% and (coupled with NARIs solid print earlier this week) reflective of strong market growth buoyed by further share gains for... More
Penumbra (PEN) PT Lowered to $232 at BTIG
October 31, 2024 5:33 AM EDTBTIG analyst Ryan Zimmerman lowered the price target on Penumbra (NYSE: PEN) to $232.00 (from $234.00) while maintaining a Buy rating.
The analyst comments "WHAT YOU SHOULD KNOW: We maintain our Buy but tweak our PT to $232 (from $234) following 3Q24 results. PEN reported revenue of $301.0M... More



